Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00841490 · ClinicalTrials.gov registry record
Oral H. Pylori Prevalence in Intellectually & Developmentally Disabled Adults
A clinical trial, sponsored by University of Louisville.
- Completed
- Registry status
- 220
- Enrollment target
NCT00841490: Completed study, sponsored by University of Louisville.
NCT00841490 is a clinical trial that has completed, run by University of Louisville. The registered enrollment target is 220 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00841490 has completed, sponsored by University of Louisville.
- COMPLETED
- Registry status
- 220 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if the bacteria that cause gastric infections can be found in the mouths of intellectually and developmentally disabled persons. If the bacteria that causes gastric infections is found in the mouth it may be swallowed and contribute to gastric infections.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 220 participants |
| Start Date | 2008-09 |
| Est. Completion | 2012-05 |
What the finished NCT00841490 record still lists
NCT00841490 is an observational study that tracks outcomes without assigning an intervention. The registered 220 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00841490 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00841490 about?
NCT00841490 is a clinical study titled "Oral H. Pylori Prevalence in Intellectually & Developmentally Disabled Adults". The purpose of this study is to determine if the bacteria that cause gastric infections can be found in the mouths of intellectually and developmentally disabled persons. If the bacteria that causes gastric infections is found in the mouth it may be swallowed and contribute to gastric infections.
What is the current status of trial NCT00841490?
This trial is currently completed. The enrollment target is 220 participants. The study started on 2008-09. Estimated completion is 2012-05.
Who is sponsoring clinical trial NCT00841490?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00920972 · 220 participants · Phase 1
Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases
- NCT01851642 · 220 participants
Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs
- NCT02582021 · 220 participants
WISE CVD - Continuation (WISE HFpEF)
- NCT04067830 · 220 participants · Phase 2
Respiratory Muscle Training Before Surgery in Preventing Lung Complications in Patients With Stage I-IIIB Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia